Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | ALPL | P05186 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | CLK1 | P49759 | 1/20 | 0.53 |
| ▸ | CHEK1 | O14757 | 9/20 | 0.52 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.47 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | GSR | P00390 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA6 | P23280 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6793273 | 0.91 | KDM4E (0.47) | KDM4EALPLHSD17B10MEN1KMT2A | |
| SCHEMBL6795109 | 0.87 | MEN1 (0.69) | KDM4EALPLHSD17B10MEN1KMT2A | |
| SCHEMBL6799356 | 0.84 | CHEK1 (0.48) | KDM4EALPLHSD17B10MEN1KMT2A | |
| SCHEMBL6792881 | 0.82 | MEN1 (0.58) | KDM4EALPLHSD17B10MEN1KMT2A | |
| SCHEMBL6787223 | 0.81 | MEN1 (0.80) | KDM4EALPLHSD17B10MEN1KMT2A | |
| SCHEMBL6787018 | 0.76 | CHEK1 (0.46) | KDM4EALPLHSD17B10MEN1KMT2A | |
| SCHEMBL6791583 | 0.76 | MEN1 (0.68) | KDM4EALPLHSD17B10MEN1KMT2A | |
| SCHEMBL6793552 | 0.75 | CCNA2 (0.54) | KDM4EALPLHSD17B10MEN1KMT2A | |
| SCHEMBL6793956 | 0.75 | MEN1 (0.43) | KDM4EALPLHSD17B10MEN1KMT2A | |
| SCHEMBL6792195 | 0.75 | MEN1 (0.46) | KDM4EALPLHSD17B10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040127492-A1 | Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 | PHARMACIA CORPORATION | 2004-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040127492-A1 | Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 | MKNK2, MAPKAPK2, MAP3K2 | KDM4E 2167/4885ALPL 3297/4885HSD17B10 2776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.